ArticleRheumatology advances in practice2026
Development of a clinical tool to identify patients with early inflammatory arthritis at high risk of employment loss: analysis from the National Early Inflammatory Arthritis Audit.
Article in Rheumatology advances in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- First-line biologic and targeted synthetic DMARDs versus methotrexate in early rheumatoid arthritis: a meta-analysis of remission outcomes.Rheumatology (Oxford, England) · 2026Pooled it
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Work disability is an early consequence of inflammatory arthritis. Preventive interventions exist but access is limited, highlighting the need for risk stratification. We aimed to develop a tool using routinely collected data to identify patients at greatest risk of employment loss. Methods: This cohort study used data from the National Early Inflammatory Arthritis Audit. Patients ≥16 years with early inflammatory arthritis (EIA), enrolled May 2018-April 2025, employed at diagnosis and with three-month follow-up were included. The outcome was self-reported employment loss at 3 months. Predictors were occupation (manual vs non-manual), age, sex, disease activity (DAS28 > 5.1), mental health (anxiety/depression) and musculoskeletal burden (MSKHQ ≤25v > 25). Employment loss was modelled using Poisson regression. Model discrimination, calibration and bootstrap validation were assessed. A risk score was derived and stratified into low, medium and high-risk groups. Results: Of 11 894 patients with EIA, 6036 were employed at baseline and 1662 had complete work-outcome data. At 3 months, 168(10.1%) reported employment loss. Manual workers had higher risk than non-manual (14.1% vs 7.8%). In multivariable analysis, manual work (IRR: 1.54, 95% CI: 1.15-2.06), older age (per 10 years: IRR: 1.65, 95% CI: 1.43-1.90), high musculoskeletal burden (IRR: 1.55, 1.10-2.19) and anxiety/depression (IRR: 1.45, 1.02-2.06) were associated with employment loss, whereas DAS28 was not. The optimal model (age, occupation, musculoskeletal and mental health) showed good discrimination (C-statistic 0.710) and calibration. An 8-point score stratified patients into low (2.5%), medium (9.1%) and high-risk (19.5%). Conclusion: Employment loss in EIA is driven by occupation, age, musculoskeletal symptoms and mental health. A risk tool incorporating these domains can stratify patients and guide targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.